{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:09:55Z","timestamp":1790633395893,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Ningbo in Zhejiang Province","award":["No. 2022J255"],"award-info":[{"award-number":["No. 2022J255"]}]},{"name":"Zhejiang Medical and Health Science and Technology Plan","award":["NO.2023KY1042"],"award-info":[{"award-number":["NO.2023KY1042"]}]},{"name":"Huili Fund","award":["2022FZ003"],"award-info":[{"award-number":["2022FZ003"]}]},{"name":"Ningbo Major Research and Development Plan Project","award":["2024Z215"],"award-info":[{"award-number":["2024Z215"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-03929-1","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T09:01:22Z","timestamp":1744102882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genomic and molecular characterization of a ceftazidime-avibactam resistant Klebsiella pneumoniae strain isolated from a Chinese tertiary hospital"],"prefix":"10.1186","volume":"25","author":[{"given":"Yanye","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"3929_CR1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.scitotenv.2019.06.533","volume":"15","author":"MD Ekwanzala","year":"2019","unstructured":"Ekwanzala MD, Dewar JB, Kamika I, Momba MNB. Tracking the environmental dissemination of carbapenem-resistant Klebsiella pneumoniae using whole genome sequencing. Sci Total Environ Nov. 2019;15:691:80\u201392. https:\/\/doi.org\/10.1016\/j.scitotenv.2019.06.533","journal-title":"Sci Total Environ Nov"},{"key":"3929_CR2","doi-asserted-by":"publisher","first-page":"634349","DOI":"10.3389\/fmed.2021.634349","volume":"8","author":"S Mukherjee","year":"2021","unstructured":"Mukherjee S, Mitra S, Dutta S, Basu S. Neonatal sepsis: the impact of Carbapenem-Resistant and hypervirulent Klebsiella pneumoniae. Front Med (Lausanne). 2021;8:634349. https:\/\/doi.org\/10.3389\/fmed.2021.634349","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"3929_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12879-017-2297-9","volume":"10","author":"A Micozzi","year":"2017","unstructured":"Micozzi A, Gentile G, Minotti C, et al. Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias. BMC Infect Dis Mar. 2017;10(1):203. https:\/\/doi.org\/10.1186\/s12879-017-2297-9","journal-title":"BMC Infect Dis Mar"},{"key":"3929_CR4","doi-asserted-by":"publisher","first-page":"e1571","DOI":"10.1002\/wsbm.1571","volume":"26","author":"L Xiong","year":"2022","unstructured":"Xiong L, Wang X, Wang Y, et al. Molecular mechanisms underlying bacterial resistance to Ceftazidime\/avibactam. WIREs mechanisms of disease. Jul. 2022;26:e1571. https:\/\/doi.org\/10.1002\/wsbm.1571","journal-title":"Jul"},{"key":"3929_CR5","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.2147\/tcrm.s120811","volume":"12","author":"KJ Goodlet","year":"2016","unstructured":"Goodlet KJ, Nicolau DP, Nailor MD. Ceftolozane\/tazobactam and Ceftazidime\/avibactam for the treatment of complicated intra-abdominal infections. Ther Clin Risk Manag. 2016;12:1811\u201326. https:\/\/doi.org\/10.2147\/tcrm.s120811","journal-title":"Ther Clin Risk Manag"},{"key":"3929_CR6","doi-asserted-by":"publisher","unstructured":"Chahine EB, Sourial M, Ortiz R, Ceftazidime\/Avibactam. A new antibiotic for Gram-Negative infections. Consultant Pharmacist: J Am Soc Consultant Pharmacists Dec. 2015;30(12):695\u2013705. https:\/\/doi.org\/10.4140\/TCP.n.2015.695","DOI":"10.4140\/TCP.n.2015.695"},{"issue":"2","key":"3929_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s40265-013-0013-7","volume":"73","author":"GG Zhanel","year":"2013","unstructured":"Zhanel GG, Lawson CD, Adam H, et al. Ceftazidime-avibactam: a novel cephalosporin\/\u03b2-lactamase inhibitor combination. Drugs Feb. 2013;73(2):159\u201377. https:\/\/doi.org\/10.1007\/s40265-013-0013-7","journal-title":"Drugs Feb"},{"key":"3929_CR8","doi-asserted-by":"publisher","unstructured":"Venditti C, Nisii C, Ballardini M, Meledandri M, Di Caro A. Identification of L169P mutation in the omega loop of KPC-3 after a short course of ceftazidime\/avibactam. The Journal of antimicrobial chemotherapy. Aug 1. 2019;74(8):2466\u20132467. https:\/\/doi.org\/10.1093\/jac\/dkz201","DOI":"10.1093\/jac\/dkz201"},{"key":"3929_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jgar.2022.07.017","volume":"30","author":"I Machuca","year":"2022","unstructured":"Machuca I, Guzm\u00e1n-Puche J, P\u00e9rez-Nadales E, et al. Community-acquired bacteraemia by Klebsiella pneumoniae producing KPC-3 and resistant to Ceftazidime\/avibactam. J Global Antimicrob Resist Sep. 2022;30:399\u2013402. https:\/\/doi.org\/10.1016\/j.jgar.2022.07.017","journal-title":"J Global Antimicrob Resist Sep"},{"key":"3929_CR10","doi-asserted-by":"publisher","first-page":"e0048722","DOI":"10.1128\/msphere.00487-22","volume":"14","author":"S Shen","year":"2022","unstructured":"Shen S, Tang C, Ding L, et al. Identification of KPC-112 from an ST15 Klebsiella pneumoniae strain conferring resistance to Ceftazidime-Avibactam. mSphere Nov. 2022;14:e0048722. https:\/\/doi.org\/10.1128\/msphere.00487-22","journal-title":"mSphere Nov"},{"key":"3929_CR11","doi-asserted-by":"publisher","first-page":"707499","DOI":"10.3389\/fphar.2021.707499","volume":"12","author":"D Li","year":"2021","unstructured":"Li D, Fei F, Yu H, et al. Ceftazidime-Avibactam therapy versus Ceftazidime-Avibactam-Based combination therapy in patients with Carbapenem-Resistant Gram-Negative pathogens: A Meta-Analysis. Front Pharmacol. 2021;12:707499. https:\/\/doi.org\/10.3389\/fphar.2021.707499","journal-title":"Front Pharmacol"},{"issue":"8","key":"3929_CR12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/phar.1622","volume":"35","author":"EJ Zasowski","year":"2015","unstructured":"Zasowski EJ, Rybak JM, Rybak MJ. The \u03b2-Lactams strike back: Ceftazidime-Avibactam. Pharmacotherapy Aug. 2015;35(8):755\u201370. https:\/\/doi.org\/10.1002\/phar.1622","journal-title":"Pharmacotherapy Aug"},{"issue":"1","key":"3929_CR13","doi-asserted-by":"publisher","first-page":"116372","DOI":"10.1016\/j.diagmicrobio.2024.116372","volume":"110","author":"S Amadesi","year":"2024","unstructured":"Amadesi S, Amedeo A, Rinaldi M, Palombo M, Giannella M, Gaibani P. In vivo emergence of Cefiderocol and Ceftazidime\/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following Ceftazidime\/avibactam -based therapies. Diagn Microbiol Infect Disease Sep. 2024;110(1):116372. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116372","journal-title":"Diagn Microbiol Infect Disease Sep"},{"issue":"6","key":"3929_CR14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/s1473-3099(16)30025-1","volume":"16","author":"FME Wagenlehner","year":"2016","unstructured":"Wagenlehner FME, Naber KG. Studying ceftazidime-avibactam in selected populations. Lancet Infect Dis Jun. 2016;16(6):621\u20133. https:\/\/doi.org\/10.1016\/s1473-3099(16)30025-1","journal-title":"Lancet Infect Dis Jun"},{"key":"3929_CR15","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3389\/fmicb.2020.01365","volume":"11","author":"X Cui","year":"2020","unstructured":"Cui X, Shan B, Zhang X, et al. Reduced Ceftazidime-Avibactam susceptibility in KPC-Producing Klebsiella pneumoniae from patients without Ceftazidime-Avibactam use History - A multicenter study in China. Front Microbiol. 2020;11:1365. https:\/\/doi.org\/10.3389\/fmicb.2020.01365","journal-title":"Front Microbiol"},{"key":"3929_CR16","doi-asserted-by":"publisher","first-page":"930777","DOI":"10.3389\/fmicb.2022.930777","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang L, Shen W, Zhang R, Cai J. Identification of a novel Ceftazidime-Avibactam-Resistant KPC-2 variant, KPC-123, in citrobacter Koseri following Ceftazidime-Avibactam treatment. Front Microbiol. 2022;13:930777. https:\/\/doi.org\/10.3389\/fmicb.2022.930777","journal-title":"Front Microbiol"},{"key":"3929_CR17","doi-asserted-by":"publisher","first-page":"1407219","DOI":"10.3389\/fcimb.2024.1407219","volume":"14","author":"Y Tu","year":"2024","unstructured":"Tu Y, Gao H, Zhao R, Yan J, Wu X. Molecular characteristics and pathogenic mechanisms of KPC-3 producing hypervirulent carbapenem-resistant Klebsiella pneumoniae (ST23-K1). Front Cell Infect Microbiol. 2024;14:1407219. https:\/\/doi.org\/10.3389\/fcimb.2024.1407219","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"3929_CR18","doi-asserted-by":"publisher","first-page":"e0021321","DOI":"10.1128\/jcm.00213-21","volume":"18","author":"R Humphries","year":"2021","unstructured":"Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of changes to the clinical and laboratory standards Institute performance standards for antimicrobial susceptibility testing, M100, 31st edition. J Clin Microbiol Nov. 2021;18(12):e0021321. https:\/\/doi.org\/10.1128\/jcm.00213-21","journal-title":"J Clin Microbiol Nov"},{"issue":"3","key":"3929_CR19","doi-asserted-by":"publisher","first-page":"e0027621","DOI":"10.1128\/jcm.00276-21","volume":"16","author":"CG Giske","year":"2022","unstructured":"Giske CG, Turnidge J, Cant\u00f3n R, Kahlmeter G. Update from the European committee on antimicrobial susceptibility testing (EUCAST). J Clin Microbiol Mar. 2022;16(3):e0027621. https:\/\/doi.org\/10.1128\/jcm.00276-21","journal-title":"J Clin Microbiol Mar"},{"key":"3929_CR20","doi-asserted-by":"publisher","first-page":"105627","DOI":"10.1016\/j.ebiom.2025.105627","volume":"113","author":"J Jiang","year":"2025","unstructured":"Jiang J, Wang L, Hu Y, et al. Global emergence of Carbapenem-resistant hypervirulent Klebsiella pneumoniae driven by an IncFII(K34) KPC-2 plasmid. EBioMedicine Mar 1. 2025;113:105627. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105627","journal-title":"EBioMedicine Mar 1"},{"issue":"5","key":"3929_CR21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.gpb.2015.08.002","volume":"13","author":"A Rhoads","year":"2015","unstructured":"Rhoads A, Au KF. PacBio sequencing and its applications. Genomics Proteom Bioinf Oct. 2015;13(5):278\u201389. https:\/\/doi.org\/10.1016\/j.gpb.2015.08.002","journal-title":"Genomics Proteom Bioinf Oct"},{"issue":"D1","key":"3929_CR22","doi-asserted-by":"publisher","first-page":"D613","DOI":"10.1093\/nar\/gkz904","volume":"8","author":"M Urban","year":"2020","unstructured":"Urban M, Cuzick A, Seager J, et al. PHI-base: the pathogen-host interactions database. Nucleic Acids Res Jan. 2020;8(D1):D613\u201320. https:\/\/doi.org\/10.1093\/nar\/gkz904","journal-title":"Nucleic Acids Res Jan"},{"issue":"1","key":"3929_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nmeth.3176","volume":"12","author":"B Buchfink","year":"2015","unstructured":"Buchfink B, Xie C, Huson DH. Fast and sensitive protein alignment using DIAMOND. Nat Methods Jan. 2015;12(1):59\u201360. https:\/\/doi.org\/10.1038\/nmeth.3176","journal-title":"Nat Methods Jan"},{"issue":"D1","key":"3929_CR24","doi-asserted-by":"publisher","first-page":"D566","DOI":"10.1093\/nar\/gkw1004","volume":"4","author":"B Jia","year":"2017","unstructured":"Jia B, Raphenya AR, Alcock B, et al. CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res Jan. 2017;4(D1):D566\u201373. https:\/\/doi.org\/10.1093\/nar\/gkw1004","journal-title":"Nucleic Acids Res Jan"},{"issue":"D1","key":"3929_CR25","doi-asserted-by":"publisher","first-page":"D912","DOI":"10.1093\/nar\/gkab1107","volume":"7","author":"B Liu","year":"2022","unstructured":"Liu B, Zheng D, Zhou S, Chen L, Yang J. VFDB 2022: a general classification scheme for bacterial virulence factors. Nucleic Acids Res Jan. 2022;7(D1):D912\u20137. https:\/\/doi.org\/10.1093\/nar\/gkab1107","journal-title":"Nucleic Acids Res Jan"},{"key":"3929_CR26","doi-asserted-by":"publisher","unstructured":"Rasche H, Hiltemann S. Galactic circos: User-friendly circos plots within the galaxy platform. Gigascience Jun. 2020;1(6). https:\/\/doi.org\/10.1093\/gigascience\/giaa065","DOI":"10.1093\/gigascience\/giaa065"},{"key":"3929_CR27","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.2147\/idr.S330362","volume":"14","author":"M Sun","year":"2021","unstructured":"Sun M, Xiao W, Xu Q. IncN1 ST7 epidemic plasmid carrying blaIMP-4 in one ST85-Type Klebsiella Oxytoca clinical isolate with Porin deficiency. Infect Drug Resist. 2021;14:3827\u201335. https:\/\/doi.org\/10.2147\/idr.S330362","journal-title":"Infect Drug Resist"},{"key":"3929_CR28","doi-asserted-by":"publisher","unstructured":"Liu Z, Wang Z, Lu X, et al. Structural diversity, fitness cost, and stability of a Bla(NDM-1)-Bearing cointegrate plasmid in Klebsiella pneumoniae and Escherichia coli. Microorganisms Nov. 2021;25(12). https:\/\/doi.org\/10.3390\/microorganisms9122435","DOI":"10.3390\/microorganisms9122435"},{"issue":"12","key":"3929_CR29","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.jiph.2022.10.020","volume":"15","author":"X Zhang","year":"2022","unstructured":"Zhang X, Chen L, Zhang X, et al. Emergence of coexistence of a novel bla(NDM-5)-harbouring IncI1-I plasmid and an mcr-1.1-harbouring IncHI2 plasmid in a clinical Escherichia coli isolate in China. J Infect Public Health Dec. 2022;15(12):1363\u20139. https:\/\/doi.org\/10.1016\/j.jiph.2022.10.020","journal-title":"J Infect Public Health Dec"},{"key":"3929_CR30","doi-asserted-by":"publisher","unstructured":"El Haddad L, Angelidakis G, Clark JR, et al. Genomic and functional characterization of Vancomycin-Resistant Enterococci-Specific bacteriophages in the galleria Mellonella wax moth larvae model. Pharm Jul. 2022;30(8). https:\/\/doi.org\/10.3390\/pharmaceutics14081591","DOI":"10.3390\/pharmaceutics14081591"},{"key":"3929_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-1-4939-8940-9_13","volume":"1898","author":"F Kamal","year":"2019","unstructured":"Kamal F, Peters DL, McCutcheon JG, Dunphy GB, Dennis JJ. Use of greater wax moth larvae (Galleria mellonella) as an alternative animal infection model for analysis of bacterial pathogenesis. Methods Mol Biol. 2019;1898:163\u201371. https:\/\/doi.org\/10.1007\/978-1-4939-8940-9_13","journal-title":"Methods Mol Biol"},{"key":"3929_CR32","doi-asserted-by":"publisher","first-page":"e6150","DOI":"10.7717\/peerj.6150","volume":"6","author":"RJ Hernandez","year":"2019","unstructured":"Hernandez RJ, Hesse E, Dowling AJ, et al. Using the wax moth larva galleria Mellonella infection model to detect emerging bacterial pathogens. PeerJ. 2019;6:e6150. https:\/\/doi.org\/10.7717\/peerj.6150","journal-title":"PeerJ"},{"key":"3929_CR33","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.2147\/idr.S461666","volume":"17","author":"M Jiang","year":"2024","unstructured":"Jiang M, Zhang H, Lu W, et al. Molecular characteristics of virulence genes in Carbapenem-Resistant and Carbapenem-Sensitive Klebsiella pneumoniae in relation to different capsule serotypes in Ningbo, China. Infect Drug Resist. 2024;17:2109\u201320. https:\/\/doi.org\/10.2147\/idr.S461666","journal-title":"Infect Drug Resist"},{"issue":"12","key":"3929_CR34","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.tim.2011.09.005","volume":"19","author":"P Nordmann","year":"2011","unstructured":"Nordmann P, Poirel L, Walsh TR, Livermore DM. The emerging NDM carbapenemases. Trends Microbiol Dec. 2011;19(12):588\u201395. https:\/\/doi.org\/10.1016\/j.tim.2011.09.005","journal-title":"Trends Microbiol Dec"},{"issue":"4","key":"3929_CR35","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.diagmicrobio.2013.09.001","volume":"77","author":"P Giakkoupi","year":"2013","unstructured":"Giakkoupi P, Tryfinopoulou K, Kontopidou F, et al. Emergence of NDM-producing Klebsiella pneumoniae in Greece. Diagnostic microbiology and infectious disease. Dec. 2013;77(4):382\u20134. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2013.09.001","journal-title":"Dec"},{"issue":"1","key":"3929_CR36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1128\/aac.01243-15","volume":"60","author":"AM Wailan","year":"2016","unstructured":"Wailan AM, Paterson DL, Kennedy K, Ingram PR, Bursle E, Sidjabat HE. Genomic characteristics of NDM-Producing Enterobacteriaceae isolates in Australia and their BlaNDM genetic contexts. Antimicrob Agents Chemother Jan. 2016;60(1):136\u201341. https:\/\/doi.org\/10.1128\/aac.01243-15","journal-title":"Antimicrob Agents Chemother Jan"},{"issue":"2","key":"3929_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.diagmicrobio.2011.06.013","volume":"71","author":"G Peirano","year":"2011","unstructured":"Peirano G, Pillai DR, Pitondo-Silva A, Richardson D, Pitout JD. The characteristics of NDM-producing Klebsiella pneumoniae from Canada. Diagn Microbiol Infect Disease Oct. 2011;71(2):106\u20139. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2011.06.013","journal-title":"Diagn Microbiol Infect Disease Oct"},{"issue":"2","key":"3929_CR38","doi-asserted-by":"publisher","first-page":"e0215621","DOI":"10.1128\/spectrum.02156-21","volume":"27","author":"H Dong","year":"2022","unstructured":"Dong H, Li Y, Cheng J, et al. Genomic epidemiology insights on NDM-Producing pathogens revealed the pivotal role of plasmids on bla(NDM) transmission. Microbiology spectrum. Apr. 2022;27(2):e0215621. https:\/\/doi.org\/10.1128\/spectrum.02156-21","journal-title":"Apr"},{"key":"3929_CR39","doi-asserted-by":"publisher","unstructured":"Shrestha B, Tada T, Miyoshi-Akiyama T, et al. Identification of a novel NDM variant, NDM-13, from a multidrug-resistant Escherichia coli clinical isolate in Nepal. Antimicrob Agents Chemother. Sep 2015;59(9):5847\u201350. https:\/\/doi.org\/10.1128\/aac.00332-15","DOI":"10.1128\/aac.00332-15"},{"key":"3929_CR40","doi-asserted-by":"publisher","unstructured":"Farooq S, Khan AU. Current update on new Delhi Metallo-\u03b2-lactamase (NDM) variants: new challenges in the journey of evolution. Curr Protein Pept Sci Aug. 2023;16. https:\/\/doi.org\/10.2174\/1389203724666230816154117","DOI":"10.2174\/1389203724666230816154117"},{"issue":"3","key":"3929_CR41","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/jac\/dkt445","volume":"69","author":"LF Mataseje","year":"2014","unstructured":"Mataseje LF, Boyd DA, Lefebvre B, et al. Complete sequences of a novel blaNDM-1-harbouring plasmid from Providencia rettgeri and an FII-type plasmid from Klebsiella pneumoniae identified in Canada. J Antimicrob Chemother Mar. 2014;69(3):637\u201342. https:\/\/doi.org\/10.1093\/jac\/dkt445","journal-title":"J Antimicrob Chemother Mar"},{"issue":"9","key":"3929_CR42","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/ismej.2011.27","volume":"5","author":"X Wang","year":"2011","unstructured":"Wang X, Wood TK. IS5 inserts upstream of the master motility Operon FlhDC in a quasi-Lamarckian way. ISME J Sep. 2011;5(9):1517\u201325. https:\/\/doi.org\/10.1038\/ismej.2011.27","journal-title":"ISME J Sep"},{"issue":"11","key":"3929_CR43","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1128\/aac.05202-11","volume":"55","author":"G Cuzon","year":"2011","unstructured":"Cuzon G, Naas T, Nordmann P. Functional characterization of Tn4401, a Tn3-based transposon involved in BlaKPC gene mobilization. Antimicrob Agents Chemother Nov. 2011;55(11):5370\u20133. https:\/\/doi.org\/10.1128\/aac.05202-11","journal-title":"Antimicrob Agents Chemother Nov"},{"key":"3929_CR44","doi-asserted-by":"publisher","first-page":"102530","DOI":"10.1016\/j.plasmid.2020.102530","volume":"111","author":"CJ Harmer","year":"2020","unstructured":"Harmer CJ, Pong CH, Hall RM. Structures bounded by directly-oriented members of the IS26 family are pseudo-compound transposons. Plasmid Sep. 2020;111:102530. https:\/\/doi.org\/10.1016\/j.plasmid.2020.102530","journal-title":"Plasmid Sep"},{"issue":"1","key":"3929_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13100-021-00239-x","volume":"23","author":"A Varani","year":"2021","unstructured":"Varani A, He S, Siguier P, Ross K, Chandler M. The IS6 family, a clinically important group of insertion sequences including IS26. Mob DNA Mar. 2021;23(1):11. https:\/\/doi.org\/10.1186\/s13100-021-00239-x","journal-title":"Mob DNA Mar"},{"key":"3929_CR46","doi-asserted-by":"publisher","unstructured":"Wu W, Feng Y, Tang G, Qiao F, McNally A, Zong Z. NDM Metallo-\u03b2-Lactamases and their bacterial producers in health care settings. Clin Microbiol Reviews Mar. 2019;20(2). https:\/\/doi.org\/10.1128\/cmr.00115-18","DOI":"10.1128\/cmr.00115-18"},{"key":"3929_CR47","doi-asserted-by":"publisher","unstructured":"Mohamed NM, Zakaria AS, Edward EA. Genomic characterization of international High-Risk clone ST410 Escherichia coli Co-Harboring ESBL-Encoding genes and bla(NDM-5) on IncFIA\/IncFIB\/IncFII\/IncQ1 multireplicon plasmid and carrying a Chromosome-Borne bla(CMY-2) from Egypt. Antibiot (Basel Switzerland) Jul. 2022;30(8). https:\/\/doi.org\/10.3390\/antibiotics11081031","DOI":"10.3390\/antibiotics11081031"},{"key":"3929_CR48","doi-asserted-by":"publisher","unstructured":"Ma T, Fu J, Xie N, et al. Fitness cost of bla(NDM-5)-Carrying p3R-IncX3 plasmids in Wild-Type NDM-Free Enterobacteriaceae. Microorganisms Mar. 2020;7(3). https:\/\/doi.org\/10.3390\/microorganisms8030377","DOI":"10.3390\/microorganisms8030377"},{"issue":"12","key":"3929_CR49","doi-asserted-by":"publisher","first-page":"7548","DOI":"10.1128\/aac.03911-14","volume":"58","author":"P Yang","year":"2014","unstructured":"Yang P, Xie Y, Feng P, Zong Z. blaNDM-5 carried by an IncX3 plasmid in Escherichia coli sequence type 167. Antimicrob Agents Chemother Dec. 2014;58(12):7548\u201352. https:\/\/doi.org\/10.1128\/aac.03911-14","journal-title":"Antimicrob Agents Chemother Dec"},{"issue":"Suppl 2","key":"3929_CR50","doi-asserted-by":"publisher","first-page":"S237","DOI":"10.1093\/infdis\/jiz519","volume":"16","author":"K Ma","year":"2020","unstructured":"Ma K, Feng Y, Liu L, Yao Z, Zong Z. A cluster of Colistin- and Carbapenem-Resistant Klebsiella pneumoniae carrying blaNDM-1 and mcr-8.2. J Infect Dis Mar. 2020;16(Suppl 2):S237\u201342. https:\/\/doi.org\/10.1093\/infdis\/jiz519","journal-title":"J Infect Dis Mar"},{"key":"3929_CR51","doi-asserted-by":"publisher","unstructured":"Chen L, Kreiswirth BN. Jan. Convergence of carbapenem-resistance and hypervirulence in Klebsiella pneumoniae. The Lancet Infectious diseases. 2018;18(1):2\u20133. https:\/\/doi.org\/10.1016\/s1473-3099(17)30517-0","DOI":"10.1016\/s1473-3099(17)30517-0"},{"key":"3929_CR52","doi-asserted-by":"publisher","unstructured":"Liu Z, Gu Y, Li X et al. Mar. Identification and characterization of NDM-1-producing hypervirulent (Hypermucoviscous) Klebsiella pneumoniae in China. Annals of laboratory medicine. 2019;39(2):167\u201375. https:\/\/doi.org\/10.3343\/alm.2019.39.2.167","DOI":"10.3343\/alm.2019.39.2.167"},{"key":"3929_CR53","doi-asserted-by":"publisher","first-page":"699913","DOI":"10.3389\/fmicb.2021.699913","volume":"12","author":"C Li","year":"2021","unstructured":"Li C, Pan D, Li M, et al. Aerobactin-Mediated iron acquisition enhances biofilm formation, oxidative stress resistance, and virulence of yersinia pseudotuberculosis. Front Microbiol. 2021;12:699913. https:\/\/doi.org\/10.3389\/fmicb.2021.699913","journal-title":"Front Microbiol"},{"key":"3929_CR54","doi-asserted-by":"publisher","first-page":"105746","DOI":"10.1016\/j.micpath.2022.105746","volume":"3","author":"R Han","year":"2022","unstructured":"Han R, Niu M, Liu S, Mao J, Yu Y, Du Y. The effect of siderophore virulence genes EntB and YbtS on the virulence of Carbapenem-resistant Klebsiella pneumoniae. Microb Pathogenesis Sep. 2022;3:171:105746. https:\/\/doi.org\/10.1016\/j.micpath.2022.105746","journal-title":"Microb Pathogenesis Sep"},{"issue":"11","key":"3929_CR55","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1128\/iai.00412-13","volume":"81","author":"TA Nagy","year":"2013","unstructured":"Nagy TA, Moreland SM, Andrews-Polymenis H, Detweiler CS. The ferric Enterobactin transporter fep is required for persistent Salmonella enterica serovar typhimurium infection. Infect Immun Nov. 2013;81(11):4063\u201370. https:\/\/doi.org\/10.1128\/iai.00412-13","journal-title":"Infect Immun Nov"},{"issue":"1","key":"3929_CR56","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13073-018-0587-5","volume":"29","author":"MMC Lam","year":"2018","unstructured":"Lam MMC, Wyres KL, Judd LM, et al. Tracking key virulence loci encoding aerobactin and Salmochelin siderophore synthesis in Klebsiella pneumoniae. Genome medicine. Oct. 2018;29(1):77. https:\/\/doi.org\/10.1186\/s13073-018-0587-5","journal-title":"Oct"},{"issue":"11","key":"3929_CR57","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3760\/cma.j.cn112150-20210730-00732","volume":"6","author":"MY Guo","year":"2021","unstructured":"Guo MY, Liu Y, Fei B, et al. [Research progress on virulence factors of hypervirulent Klebsiella pneumoniae]. Zhonghua Yu Fang Yi Xue Za Zhi [Chinese journal of preventive medicine]. Nov. 2021;6(11):1357\u201363. https:\/\/doi.org\/10.3760\/cma.j.cn112150-20210730-00732","journal-title":"Nov"},{"key":"3929_CR58","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.3389\/fmicb.2019.02436","volume":"10","author":"TH Lin","year":"2019","unstructured":"Lin TH, Wu CC, Kuo JT, Chu HF, Lee DY, Lin CT. FNR-Dependent RmpA and RmpA2 regulation of capsule polysaccharide biosynthesis in Klebsiella pneumoniae. Front Microbiol. 2019;10:2436. https:\/\/doi.org\/10.3389\/fmicb.2019.02436","journal-title":"Front Microbiol"},{"key":"3929_CR59","doi-asserted-by":"publisher","first-page":"100594","DOI":"10.1016\/j.onehlt.2023.100594","volume":"17","author":"F Esposito","year":"2023","unstructured":"Esposito F, Cardoso B, Sellera FP, et al. Expansion of healthcare-associated hypervirulent KPC-2-producing Klebsiella pneumoniae ST11\/KL64 beyond hospital settings. One Health Dec. 2023;17:100594. https:\/\/doi.org\/10.1016\/j.onehlt.2023.100594","journal-title":"One Health Dec"},{"key":"3929_CR60","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jgar.2022.06.002","volume":"30","author":"J Wang","year":"2022","unstructured":"Wang J, Tang B, Lin R, et al. Emergence of mcr-1- and bla(NDM-5)-harbouring IncHI2 plasmids in Escherichia coli strains isolated from meat in Zhejiang, China. J Global Antimicrob Resist Sep. 2022;30:103\u20136. https:\/\/doi.org\/10.1016\/j.jgar.2022.06.002","journal-title":"J Global Antimicrob Resist Sep"},{"issue":"3","key":"3929_CR61","doi-asserted-by":"publisher","first-page":"383","DOI":"10.33073\/pjm-2024-034","volume":"1","author":"N Gao","year":"2024","unstructured":"Gao N, Zhou J, Li G, Liu R, Lu G, Shen J. Methodological evaluation of carbapenemase detection by different methods. Pol J Microbiol Sep. 2024;1(3):383\u201394. https:\/\/doi.org\/10.33073\/pjm-2024-034","journal-title":"Pol J Microbiol Sep"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03929-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-03929-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03929-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T17:13:37Z","timestamp":1744218817000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-03929-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3929"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-03929-1","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are accountable for all aspects of the work and ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. This study was approved by the Ethics Committee of Ningbo Medical Centre Lihuili Hospital (No.KY2022SL390-01), and informed consent was obtained from the study participants prior to its implementation. The investigation was conducted in accordance with the guidelines of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"199"}}